Position in GSK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,320,044,004
-$70,994,448 QoQ
Shares Held
25,182,068
-0.1% QoQ
Ownership
1.26%
of shares outstanding
% of Portfolio
0.78%
of 13F equity value
Holder Rank
#4
of 1,033 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PRIMECAP MANAGEMENT CO/CA/ holds $23,952,609,496 across 9 Drug Manufacturers - General names. GSK ranks #6 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
9,172,904 | $11,002,257,162 | |
| 2 | AZN |
Astrazeneca PLC
|
18,095,178 | $3,431,207,652 | |
| 3 | BIIB |
Biogen Inc.
|
15,154,606 | $3,274,304,172 | |
| 4 | AMGN |
Amgen Inc
|
6,756,962 | $2,446,831,079 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
24,923,900 | $1,436,115,118 | |
| 6 | GSK |
GSK plc
This page
|
25,182,068 | $1,320,044,004 | |
| 7 | NVS |
Novartis AG
|
6,592,124 | $1,033,117,673 | |
| 8 | MRK |
Merck & Co., Inc.
|
35,700 | $4,587,450 |
All Filings in GSK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,320,044,004 | 25,182,068 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,391,038,452 | 25,204,538 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,232,383,046 | 25,130,160 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1,112,101,562 | 25,766,950 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,064,708,352 | 27,726,780 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $995,928,694 | 25,708,020 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $854,349,341 | 25,261,660 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $607,221,504 | 14,853,755 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $558,688,515 | 14,511,390 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $546,093,921 | 12,738,370 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $448,032,052 | 12,089,370 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $437,130,412 | 12,058,770 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $419,545,882 | 11,771,770 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $351,228,325 | 9,871,510 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $132,334,428 | 3,765,920 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $12,982,161 | 441,120 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $23,541,595 | 551,400 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $23,557,819 | 551,400 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $23,849,858 | 551,400 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $20,664,469 | 551,400 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $21,535,178 | 551,400 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $19,578,157 | 559,300 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $20,187,060 | 559,300 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $20,647,852 | 559,300 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $22,375,821 | 559,300 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $20,784,992 | 559,300 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||